Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Publications
(up to ten in the last five years)
Last Updated 9/11/2021
J Clin Oncol 2016 07 16;34(21):2557-8. Epub 2016 May 16
Date: 05 2016
dx.doi.org/10.1200/JCO.2016.67.6395
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated infection.
Leuk Res Rep 2017 18;8:4-6. Epub 2017 Jul 18.
Date: 07 2018
dx.doi.org/10.1016/j.lrr.2017.07.001
Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189.
J Thorac Dis 2018 Sep;10(9):5186-5189
Date: 09 2018
dx.doi.org/10.21037/jtd.2018.09.05
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Front Oncol 2018 15;8:669. Epub 2019 Jan 15.
Date: 01 2019
dx.doi.org/10.3389/fonc.2018.00669
Timed sequential salvage chemotherapy for relapsed or refractory acute myeloid leukemia.
Clin Hematol Int 2020 Mar 9;2(1):27-31. Epub 2019 Dec 9
Date: 12 2019
dx.doi.org/10.2991/chi.d.191128.001
Value in Oncology: Beware Putting Lipstick on a Pig.
JCO Oncol Pract 2020 08 5;16(8):439-441. Epub 2020 May 5.
Date: 05 2020
dx.doi.org/10.1200/OP.20.00114
